Answers are grounded in this paper and cite their sources.
Eleven patients with Stage I (i.e., negative lymphangiography) lymphosarcoma and 15 with Stage I reticulum-cell sarcoma were followed for at least two years. There were three deaths and six recurrences, all within 32 months of diagnosis. Twenty-four of 26 patients (92 per cent) were alive at two years, and 17 of 20 (85 per cent) at four years. Early bone-marrow invasion was seen only in the three patients who died. Six patients survived for a mean of over 111 months with nodal and extranodal recurrences. There were two deaths and six recurrences in 19 patients (42 per cent) receiving less than 3500 R (supervoltage in most cases) and only one death and no recurrences in seven patients (14 per cent) receiving at least 3500 R to the primary tumor site.
No takes yet. Share an insight, caveat, or question.
Lipton et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: